SEC Info - Phibro Animal Health Corp. - ‘10-K’ for 6/30/23

Phibro Animal Health Corp. – ‘10-K’ for 6/30/23 – ‘EX-31.1’

On: Wednesday, 8/30/23, at 4:22pm ET · For: 6/30/23 · Accession #: 1558370-23-15357 · File #: 1-36410

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/30/23 Phibro Animal Health Corp. 10-K 6/30/23 155:16M Toppan Merrill Bridge/FA

Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 4.29M 2: EX-10.18 Material Contract HTML 60K 3: EX-21.1 Subsidiaries List HTML 52K 4: EX-23.1 Consent of Expert or Counsel HTML 41K 5: EX-31.1 Certification -- §302 - SOA'02 HTML 47K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 47K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 43K 8: EX-32.2 Certification -- §906 - SOA'02 HTML 43K 14: R1 Document and Entity Information HTML 121K 15: R2 Consolidated Statements of Operations HTML 109K 16: R3 Consolidated Statements of Comprehensive Income HTML 72K 17: R4 Consolidated Balance Sheets HTML 138K 18: R5 Consolidated Balance Sheets (Parentheticals) HTML 68K 19: R6 Consolidated Statements of Cash Flows HTML 155K 20: R7 Consolidated Statements of Changes in HTML 76K Stockholders' Equity 21: R8 Consolidated Statements of Changes in HTML 44K Stockholders' Equity (Parentheticals) 22: R9 Description of Business HTML 45K 23: R10 Summary of Significant Accounting Policies and New HTML 112K Accounting Standards 24: R11 Acquisition HTML 45K 25: R12 Statements of Operations-Additional Information HTML 176K 26: R13 Balance Sheets-Additional Information HTML 246K 27: R14 Debt HTML 96K 28: R15 Leases HTML 105K 29: R16 Common Stock, Preferred Stock and Dividends HTML 73K 30: R17 Stock Incentive Plan HTML 47K 31: R18 Related Party Transactions HTML 47K 32: R19 Employee Benefit Plans HTML 238K 33: R20 Income Taxes HTML 214K 34: R21 Commitments and Contingencies HTML 56K 35: R22 Derivatives HTML 94K 36: R23 Fair Value Measurements HTML 74K 37: R24 Business Segments HTML 168K 38: R25 Summary of Significant Accounting Policies and New HTML 180K Accounting Standards (Policies) 39: R26 Summary of Significant Accounting Policies and New HTML 74K Accounting Standards (Tables) 40: R27 Statements of Operations-Additional Information HTML 171K (Tables) 41: R28 Balance Sheets-Additional Information (Tables) HTML 268K 42: R29 Debt (Tables) HTML 87K 43: R30 Leases (Tables) HTML 106K 44: R31 Common Stock, Preferred Stock and Dividends HTML 65K (Tables) 45: R32 Employee Benefit Plans (Tables) HTML 238K 46: R33 Income Taxes (Tables) HTML 218K 47: R34 Derivatives (Tables) HTML 93K 48: R35 Fair Value Measurements (Tables) HTML 66K 49: R36 Business Segments (Tables) HTML 167K 50: R37 Summary of Significant Accounting Policies and New HTML 49K Accounting Standards - Accounts Receivable and Allowance for Doubtful Accounts (Details) 51: R38 Summary of Significant Accounting Policies and New HTML 59K Accounting Standards - Property, Plant and Equipment and Capitalized Software (Details) 52: R39 Summary of Significant Accounting Policies and New HTML 46K Accounting Standards - Derivative Financial Instruments (Details) 53: R40 Summary of Significant Accounting Policies and New HTML 88K Accounting Standards - Net Income Per Share and Weighted Average Shares (Details) 54: R41 Summary of Significant Accounting Policies and New HTML 89K Accounting Standards - New Accounting Standards (Details) 55: R42 Acquisition - Consideration Transferred (Details) HTML 48K 56: R43 Acquisition - Definite-lived Intangible Assets HTML 50K (Details) 57: R44 Statements of Operations-Additional Information - HTML 44K Segments (Details) 58: R45 Statements of Operations-Additional Information - HTML 62K Net Sales by Product Type (Details) 59: R46 Statements of Operations-Additional Information - HTML 58K Net Sales by Region (Details) 60: R47 Statements of Operations-Additional Information - HTML 47K Deferred Revenue (Details) 61: R48 Statements of Operations-Additional Information - HTML 46K General Information (Details) 62: R49 Statements of Operations-Additional Information - HTML 67K Interest Expense, Net (Details) 63: R50 Statements of Operations-Additional Information - HTML 44K Capitalized Software (Details) 64: R51 Statements of Operations-Additional Information - HTML 58K Amortization of Intangible Assets (Details) 65: R52 Statements of Operations-Additional Information - HTML 52K Depreciation and Amortization (Details) 66: R53 Statements of Operations-Additional Information - HTML 45K Research and Development Expense (Details) 67: R54 Balance Sheets-Additional Information - Accounts HTML 50K Receivable, Net (Details) 68: R55 Balance Sheets-Additional Information - Reserve HTML 52K for Credit Losses (Details) 69: R56 Balance Sheets-Additional Information - HTML 51K Inventories, Net (Details) 70: R57 Balance Sheets-Additional Information - Property, HTML 59K Plant and Equipment, Net - Tabular Disclosure (Details) 71: R58 Balance Sheets-Additional Information - Property, HTML 44K Plant and Equipment, Net - Additional Information (Details) 72: R59 Balance Sheets-Additional Information - HTML 52K Intangibles, Net - Weighted-Average Useful Life (Details) 73: R60 Balance Sheets-Additional Information - HTML 59K Intangibles, Net - Total (Details) 74: R61 Balance Sheets-Additional Information - Goodwill HTML 50K (Details) 75: R62 Balance Sheets-Additional Information - Other HTML 65K Assets (Details) 76: R63 Balance Sheets-Additional Information - Equity HTML 53K Method Investments (Details) 77: R64 Balance Sheets-Additional Information - Accrued HTML 63K Expenses and Other Current Liabilities (Details) 78: R65 Balance Sheets-Additional Information - Insurance HTML 45K Premium Financing (Details) 79: R66 Balance Sheets-Additional Information - Other HTML 61K Liabilities (Details) 80: R67 Balance Sheets-Additional Information - HTML 58K Accumulated Other Comprehensive Income (Loss) (Details) 81: R68 Debt - General Information (Details) HTML 139K 82: R69 Debt - Derivatives (Details) HTML 61K 83: R70 Debt - Reconciliation (Details) HTML 61K 84: R71 Debt - Classification (Details) HTML 49K 85: R72 Debt - Aggregate Maturities of Long-Term Debt and HTML 63K Revolver (Details) 86: R73 Leases - General Information (Details) HTML 46K 87: R74 Leases - Assets and Liabilities (Details) HTML 58K 88: R75 Leases - Composition of Net Lease Cost (Details) HTML 50K 89: R76 Leases - Other Supplemental Information (Details) HTML 51K 90: R77 Leases - Maturities of Future Lease Liabilities HTML 57K (Details) 91: R78 Leases - Gross Difference (Details) HTML 48K 92: R79 Common Stock, Preferred Stock and Dividends - HTML 69K Preferred Stock and Common Stock - Tabular Disclosure (Details) 93: R80 Common Stock, Preferred Stock and Dividends - HTML 44K Preferred Stock and Common Stock - Additional Information (Details) 94: R81 Common Stock, Preferred Stock and Dividends - HTML 51K Common Stock (Details) 95: R82 Common Stock, Preferred Stock and Dividends - HTML 44K Dividends (Details) 96: R83 Stock Incentive Plan - General Information HTML 52K (Details) 97: R84 Stock Incentive Plan - Restricted Stock Units HTML 59K (Details) 98: R85 Stock Incentive Plan - Stock-Based Compensation HTML 48K Expense (Details) 99: R86 Related Party Transactions (Details) HTML 48K 100: R87 Employee Benefit Plans - General Information HTML 97K (Details) 101: R88 Employee Benefit Plans - Change in Projected HTML 53K Benefit Obligation - Tabular Disclosure (Details) 102: R89 Employee Benefit Plans - Change in Projected HTML 43K Benefit Obligation - Additional Information (Details) 103: R90 Employee Benefit Plans - Change in Plan Assets HTML 51K (Details) 104: R91 Employee Benefit Plans - Funded Status (Details) HTML 50K 105: R92 Employee Benefit Plans - Annuity Purchase HTML 51K Agreement (Details) 106: R93 Employee Benefit Plans - Accumulated Other HTML 54K Comprehensive Income (Loss) (Details) 107: R94 Employee Benefit Plans - Net Periodic Pension HTML 59K Expense (Details) 108: R95 Employee Benefit Plans - Actuarial Assumptions - HTML 49K Tabular Disclosure (Details) 109: R96 Employee Benefit Plans - Actuarial Assumptions - HTML 43K Additional Information (Details) 110: R97 Employee Benefit Plans - Estimated Future Benefit HTML 58K Payments (Details) 111: R98 Employee Benefit Plans - Asset Allocation HTML 66K (Details) 112: R99 Employee Benefit Plans - Fair Values of Plan HTML 73K Assets (Details) 113: R100 Employee Benefit Plans - Change in Fair Value of HTML 53K Level 3 Assets (Details) 114: R101 Employee Benefit Plans - Fair Value Assumptions HTML 43K (Details) 115: R102 Employee Benefit Plans - 401(k) Retirement Savings HTML 51K Plan (Details) 116: R103 Employee Benefit Plans - Other Employee Benefit HTML 46K Plans (Details) 117: R104 Income Taxes - Income (Loss) before Income Taxes HTML 52K (Details) 118: R105 Income Taxes - Components of Provision for Income HTML 72K Taxes (Details) 119: R106 Income Taxes - Reconciliation of Federal Statutory HTML 69K Rate to Effective Tax Rate (Details) 120: R107 Income Taxes - Global Intangible Low-Taxed Income HTML 44K (Details) 121: R108 Income Taxes - Foreign Tax Credit (Details) HTML 46K 122: R109 Income Taxes - Deferred Tax Assets and Liabilities HTML 82K (Details) 123: R110 Income Taxes - Deferred Taxes Included in HTML 48K Consolidated Balance Sheets (Details) 124: R111 Income Taxes - Valuation Allowance (Details) HTML 46K 125: R112 Income Taxes - Net Operating Loss Carry Forwards HTML 51K (Details) 126: R113 Income Taxes - Repatriation (Details) HTML 46K 127: R114 Income Taxes - Gross Unrecognized Tax Benefits HTML 54K Reconciliation (Details) 128: R115 Income Taxes - Liabilities Related To Uncertain HTML 48K Tax Positions (Details) 129: R116 Income Taxes - Uncertain Tax Positions (Details) HTML 44K 130: R117 Commitments and Contingencies - Environmental HTML 49K (Details) 131: R118 Commitments and Contingencies - Employment and HTML 43K Severance Agreements (Details) 132: R119 Commitments and Contingencies - Purchase HTML 48K Commitments (Details) 133: R120 Derivatives - General Information (Details) HTML 63K 134: R121 Derivatives - Balance Sheet Location (Details) HTML 57K 135: R122 Derivatives - Notional Amounts (Details) HTML 51K 136: R123 Derivatives - Effects of Derivatives (Details) HTML 63K 137: R124 Derivatives - Additional Information (Details) HTML 46K 138: R125 Fair Value Measurements - Fair Value of Assets HTML 53K (Details) 139: R126 Fair Value Measurements - Assets Measured On HTML 44K Recurring Basis, Unobservable Inputs (Details) 140: R127 Fair Value Measurements - Liabilities Measured on HTML 46K Recurring Basis, Unobservable Inputs (Details) 141: R128 Business Segments - General Information (Details) HTML 44K 142: R129 Business Segments - Net Sales (Details) HTML 53K 143: R130 Business Segments - Depreciation and Amortization HTML 53K (Details) 144: R131 Business Segments - Adjusted EBITDA (Details) HTML 51K 145: R132 Business Segments - Reconciliation of Income HTML 80K before Income Taxes to Adjusted EBITDA (Details) 146: R133 Business Segments - Identifiable Assets (Details) HTML 60K 147: R134 Business Segments - Property, Plant and Equipment, HTML 55K Net (Details) 148: R135 Subsequent Event (Details) HTML 68K 149: R136 Pay vs Performance Disclosure HTML 54K 150: R137 Insider Trading Arrangements HTML 55K 153: XML IDEA XML File -- Filing Summary XML 295K 151: XML XBRL Instance -- pahc-20230630x10k_htm XML 3.81M 152: EXCEL IDEA Workbook of Financial Report Info XLSX 246K 10: EX-101.CAL XBRL Calculations -- pahc-20230630_cal XML 336K 11: EX-101.DEF XBRL Definitions -- pahc-20230630_def XML 937K 12: EX-101.LAB XBRL Labels -- pahc-20230630_lab XML 1.86M 13: EX-101.PRE XBRL Presentations -- pahc-20230630_pre XML 1.73M 9: EX-101.SCH XBRL Schema -- pahc-20230630 XSD 287K 154: JSON XBRL Instance as JSON Data -- MetaLinks 819± 1.23M 155: ZIP XBRL Zipped Folder -- 0001558370-23-015357-xbrl Zip 740K

EXHIBIT 31.1

CERTIFICATIONS

I, Jack C. Bendheim, certify that:

1.I have reviewed this Annual Report on Form 10-K for the year ended June 30, 2023, of Phibro Animal Health Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


	Dated: August 30, 2023		/s/ *Jack C. Bendheim*
			Jack C. Bendheim
			Chairman, President and Chief Executive Officer

This ‘10-K’ Filing

Date

Other Filings

Filed on:

8/30/23

None on these Dates

For Period end:

6/30/23

List all Filings

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/08/23 Phibro Animal Health Corp. 10-Q 9/30/23 79:6.9M Toppan Merrill Bridge/FA

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/16/23 Phibro Animal Health Corp. 8-K:1,2,9 6/16/23 11:1.7M Toppan Merrill/FA 11/09/22 Phibro Animal Health Corp. 10-Q 9/30/22 78:8.4M Toppan Merrill Bridge/FA 2/09/22 Phibro Animal Health Corp. 10-Q 12/31/21 58:7M Toppan Merrill/FA2 8/25/21 Phibro Animal Health Corp. 10-K 6/30/21 104:14M Toppan Merrill/FA 4/22/21 Phibro Animal Health Corp. 8-K:1,2,9 4/22/21 12:1.7M Toppan Merrill/FA 11/04/20 Phibro Animal Health Corp. 10-Q 9/30/20 60:6.3M Toppan Merrill/FA 8/26/20 Phibro Animal Health Corp. 10-K 6/30/20 107:18M Toppan Merrill/FA 8/27/19 Phibro Animal Health Corp. 10-K 6/30/19 103:15M Toppan Merrill/FA 11/06/18 Phibro Animal Health Corp. 10-Q 9/30/18 62:4.4M Toppan Merrill/FA 5/07/18 Phibro Animal Health Corp. 8-K:1,5,9 5/07/18 2:62K Toppan Merrill/FA 9/10/15 Phibro Animal Health Corp. 10-K 6/30/15 104:11M Toppan Vite NY Inc./FA 5/11/15 Phibro Animal Health Corp. 10-Q 3/31/15 61:5.4M Toppan Vite NY Inc./FA 5/13/14 Phibro Animal Health Corp. 10-Q 3/31/14 71:11M Toppan Vite NY Inc./FA 4/04/14 Phibro Animal Health Corp. S-1/A 5:1.6M Toppan Vite NY Inc./FA 3/31/14 Phibro Animal Health Corp. S-1/A 18:16M Toppan Vite NY Inc./FA 3/10/14 Phibro Animal Health Corp. S-1¶ 32:16M Toppan Vite NY Inc./FA

Phibro Animal Health Corp. – ‘10-K’ for 6/30/23 – ‘EX-31.1’

On: Wednesday, 8/30/23, at 4:22pm ET · For: 6/30/23 · Accession #: 1558370-23-15357 · File #: 1-36410

Previous ‘10-K’: ‘10-K’ on 8/24/22 for 6/30/22 · Latest ‘10-K’: This Filing · 17 References:

Annual Report — Form 10-K

Filing Table of Contents

‘EX-31.1’ — Certification — §302 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

1 Subsequent Filing that References this Filing

16 Previous Filings that this Filing References

Phibro Animal Health Corp. – ‘10-K’ for 6/30/23 – ‘EX-31.1’

On: Wednesday, 8/30/23, at 4:22pm ET · For: 6/30/23 · Accession #: 1558370-23-15357 · File #: 1-36410

Annual Report — Form 10-KFiling Table of Contents

‘EX-31.1’ — Certification — §302 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

1 Subsequent Filing that References this Filing

16 Previous Filings that this Filing References

Annual Report — Form 10-K

Filing Table of Contents